- Home
- FDSB vs CASI Comparison
FDSB vs CASI Comparison
Compare FDSB & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDSB
- CASI
- Stock Information
- Founded
- FDSB 1926
- CASI 1991
- Country
- FDSB United States
- CASI China
- Employees
- FDSB N/A
- CASI N/A
- Industry
- FDSB
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- FDSB
- CASI Health Care
- Exchange
- FDSB NYSE
- CASI Nasdaq
- Market Cap
- FDSB 57.8M
- CASI 58.8M
- IPO Year
- FDSB N/A
- CASI 1996
- Fundamental
- Price
- FDSB $12.50
- CASI $2.94
- Analyst Decision
- FDSB
- CASI Strong Buy
- Analyst Count
- FDSB 0
- CASI 1
- Target Price
- FDSB N/A
- CASI $6.00
- AVG Volume (30 Days)
- FDSB 11.3K
- CASI 54.4K
- Earning Date
- FDSB 11-14-2024
- CASI 11-15-2024
- Dividend Yield
- FDSB N/A
- CASI N/A
- EPS Growth
- FDSB N/A
- CASI N/A
- EPS
- FDSB N/A
- CASI N/A
- Revenue
- FDSB $10,898,681.00
- CASI $22,055,000.00
- Revenue This Year
- FDSB N/A
- CASI N/A
- Revenue Next Year
- FDSB N/A
- CASI $134.79
- P/E Ratio
- FDSB N/A
- CASI N/A
- Revenue Growth
- FDSB N/A
- CASI N/A
- 52 Week Low
- FDSB $9.85
- CASI $2.05
- 52 Week High
- FDSB $12.93
- CASI $8.19
- Technical
- Relative Strength Index (RSI)
- FDSB N/A
- CASI 34.42
- Support Level
- FDSB N/A
- CASI $2.86
- Resistance Level
- FDSB N/A
- CASI $3.47
- Average True Range (ATR)
- FDSB 0.00
- CASI 0.48
- MACD
- FDSB 0.00
- CASI -0.00
- Stochastic Oscillator
- FDSB 0.00
- CASI 28.21
About FDSB FIFTH DISTRICT BANCORP INC.
Fifth District Bancorp inc is a holding company of Fifth District. Fifth District portfolio consists primarily of fixed-rate one- to four-family residential mortgage loans also originate construction loans, home equity loans, home equity lines of credit, land loans, and share loans (loans secured by deposit accounts at Fifth District) and purchase commercial business loans. The company offer a variety of deposit accounts including checking accounts, money market accounts, and certificates of deposit. In addition, it offers electronic banking services including mobile banking, on-line banking, telephone banking, bill pay, and electronic funds transfer via SmartPay..
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.